Halda Therapeutics

Drug Discovery · New Haven, CT · Founded 2018 · Privately Held (backing)

Developer of a drug discovery platform designed to create therapeutic and precision medicines. Halda Therapeutics is based in New Haven, CT and was founded in 2018. Its last known valuation is $3 billion. It has raised $227 million across 3 recorded rounds; the latest was a $126 million Series B in Jul 2024.

Last price · $/share
—
Implied valuation
$3.0B
Total raised
$227.1M
Last round
Later Stage VC (Series B)
Jul 2024

Who backs Halda Therapeutics?

14 investors
InvestorType
RA Capital ManagementAsset manager
Connecticut InnovationsVenture capital
Canaan PartnersVenture capital
Frazier Healthcare PartnersVenture capital
Deep Track CapitalVenture capital
Frazier GroupVenture capital
WuXi Healthcare VenturesOther
120 Capital—
6 Dimensions Capital—
Access Biotechnology—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Halda Therapeutics investors

14 investors are on record for Halda Therapeutics, including RA Capital Management, Connecticut Innovations, Canaan Partners and Frazier Healthcare Partners. By type, the record holds 5 venture capital firms and 1 asset manager. The Series B in Jul 2024 drew 11 investors.

Free account
More of Halda Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Halda Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Halda Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View